Skip to main content
Premium Trial:

Request an Annual Quote

University of Nebraska Selects Cartagenia's Bench for Genomic Analysis

Premium

Cartagenia said recently that the University of Nebraska Medical Center has tapped its Bench platform genetics diagnostics solution for use in its healthcare laboratory.

The cloud-based platform will provide geneticists and clinicians at the institution's human genetic laboratory — part of the university's Munroe-Meyer Institute for Genetics and Rehabilitation — with tools to analyze, interpret, and report data on genomic variants.

According to Jennifer Sanmann, a cytogenetics fellow in the lab, researchers have begun using the Bench CNV and Bench NGS tools, which have helped them keep track of lab findings and reduce report turnaround times. These tools have also "reduced significantly the amount of analysis time per case and have improved our ability to track and query identified variants," she said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.